| Cancer Mouse Models (all) |
| Bmx-Cre-ERT2 |
Conditional, inducible Cre recombinase in arterial endothelial cells (Cre-ERT under Bmx promoter) deleter mouse |
| Conditional, inducible Cre recombinase in endothelial cells (Cre-ERT under VECad promoter) deleter mouse |
| Cyl-1-/- |
Cyclin D1 knockout mouse |
| Dll1flox |
Delta like-1 floxed conditional knockout mouse |
| Fgfr2bflox/flox |
Fgfr2 IIIb floxed conditional knockout mouse |
| GSTP1/2-/- |
Glutathione S-Transferase P1 and P2 double knockout mouse |
| Inv-a6b4 |
Human a6 and b4 integrin conditional transgenic mouse (epidermal expression) |
| Jag1flox |
Jagged1 floxed conditional knockout mouse |
| K5-R2b-null |
Fgfr2 IIIb conditional knockout mouse (epidermal knockout) |
| LSL-BrafD594A |
Conditional knockin (Cre-lox) D594A mutation of BRaf |
| LSL-B-raf-V600E |
B-Raf floxed conditional knockin mouse (V600E), oncogenic mutant |
| OGG1 Knockout Mouse |
| Pdgrfb-Cre |
Conditional Cre recombinase in pericytes & vascular smooth muscle (Cre under Pdgrfb promoter) deleter mouse |
| Pik3ca |
Pi3Kinase C alpha knockin mouse (T208D, K227A), blocking Ras binding |
| Raf-1+/- |
Raf-1 knockout mouse |
| Raf-1D486A |
Raf-1 knockin mouse (D486A), oncogenic mutant |
| Raf-1FF/FF |
Raf-1 knockin mouse (Y340F Y341F), inactive mutant |
| TG4 |
Human MUC1 transgenic mouse |
| Ung-/- |
Uracil DNA Glycosylase knockout mouse |
| |
| Adenocarcinoma Mouse Models |
| TG4 |
Human MUC1 transgenic mouse |
| |
| Angiogenesis Mouse Models |
| Bmx-Cre-ERT2 |
Conditional, inducible Cre recombinase in arterial endothelial cells (Cre-ERT under Bmx promoter) deleter mouse |
| Conditional, inducible Cre recombinase in endothelial cells (Cre-ERT under VECad promoter) deleter mouse |
| Pdgrfb-Cre |
Conditional Cre recombinase in pericytes & vascular smooth muscle (Cre under Pdgrfb promoter) deleter mouse |
| VECad-Cre-ERT2 |
Conditional, inducible Cre recombinase in endothelial cells (Cre-ERT under VECad promoter) deleter mouse |
| |
| Colorectal Cancer Mouse Models |
| Cyl-1-/- |
Cyclin D1 knockout mouse |
| GSTPNull x APCMin |
GSTP and APC Knock Out |
| LSL-B-raf-V600E |
B-Raf floxed conditional knockin mouse (V600E), oncogenic mutant |
| |
| Gastric Carcinoma Mouse Models |
| K5-R2b-null |
Fgfr2 IIIb conditional knockout mouse (epidermal knockout) |
| |
| Lung Adenoma Mouse Models |
| GSTP1/2-/- |
Glutathione S-Transferase P1 and P2 double knockout mouse |
| |
| Melanoma Mouse Models |
| LSL-B-raf-V600E |
B-Raf floxed conditional knockin mouse (V600E), oncogenic mutant |
| |
| Squamous Cell Carcinoma Mouse Models |
| Inv-a6b4 |
Human a6 and b4 integrin conditional transgenic mouse (epidermal expression) |
| |
Autoimmune Disease Mouse Models |
| Dll1flox |
Delta like-1 floxed conditional knockout mouse |
| Inv-a2b1 |
Human a2 and b1 integrin conditional transgenic mouse (epidermal expression), psoriasis model |
| Inv-a3b1 |
Human a3 and b1 integrin conditional transgenic mouse (epidermal expression), psoriasis model |
| Inv-a5b1 |
Human a5 and b1 integrin conditional transgenic mouse (epidermal expression), psoriasis model |
| InvEE |
Constituitively active MEK1 conditional transgenic mouse (epidermal expression), psoriasis model |
| Inv-IFNg |
Murine interferon-g conditional transgenic mouse (epidermal expression), systemic lupus erythematosus model |
| Jag1flox |
Jagged1 floxed conditional knockout mouse |
| |
| Drug Metabolism & Toxicity Mouse Models |
| GSTP1/2-/- |
Glutathione S-Transferase P1 and P2 double knockout mouse |
| |
| Inflammatory Disease Mouse Models |
| LFA-1-/- |
Lymphocyte Function-associated Antigen 1 knockout mouse |
| |
| Systemic Lupus Erythematosus Mouse Models |
| Inv-IFNg |
Murine interferon-g conditional transgenic mouse (epidermal expression), systemic lupus erythematosus model |
| |
| Neuropathic Disease Mouse Models |
| |
|
| |
| Psoriasis Mouse Models |
| Inv-a2b1 |
Human a2 and b1 integrin conditional transgenic mouse (epidermal expression), psoriasis model |
| Inv-a3b1 |
Human a3 and b1 integrin conditional transgenic mouse (epidermal expression), psoriasis model |
| Inv-a5b1 |
Human a5 and b1 integrin conditional transgenic mouse (epidermal expression), psoriasis model |
| InvEE |
Constituitively active MEK1 conditional transgenic mouse (epidermal expression), psoriasis model |
| |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
